Medtronic PLC
MDT89.220USD
-1.020-1.13%
Market hours （ET）Quotes delayed by 15 min
114.37BMarket Cap
24.53P/E TTM
More Details of Medtronic PLC Company
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Company Info
Ticker SymbolMDT
Company nameMedtronic PLC
IPO dateNov 21, 1977
Founded at2014
CEOMr. Geoffrey S. (Geoff) Martha
Number of employees95000
Security typeOrdinary Share
Fiscal year-endNov 21
AddressBuilding Two Parkmore Business Park West
CityDUBLIN
Stock exchangeNYSE Consolidated
CountryIreland
Postal codeH91 4K49
Phone1135314381700
Websitehttps://www.medtronic.com/
Ticker SymbolMDT
IPO dateNov 21, 1977
Founded at2014
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.06M
+3.66%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
496.43K
+2.01%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
120.89K
+8.81%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
48.79K
+25.09%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
47.95K
+4.05%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.16K
+4.88%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
39.45K
+28.29%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.52K
+9.50%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.06M
+3.66%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President, President - Cardiovascular Portfolio
Executive Vice President, President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
496.43K
+2.01%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
120.89K
+8.81%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
48.79K
+25.09%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Other
9.18B
27.37%
By RegionUSD
Name
Revenue
Proportion
United States
17.17B
51.20%
Rest of World
16.25B
48.45%
Ireland
116.00M
0.35%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Other
9.18B
27.37%
Shareholding Stats
Updated: Sat, Jul 26
Updated: Sat, Jul 26
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.71%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.69%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.79%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.71%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.69%
Capital Research Global Investors
3.24%
JP Morgan Asset Management
2.18%
Other
74.79%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.74%
Investment Advisor/Hedge Fund
29.28%
Research Firm
3.90%
Pension Fund
2.28%
Bank and Trust
2.02%
Hedge Fund
1.92%
Sovereign Wealth Fund
1.24%
Insurance Company
0.38%
Individual Investor
0.25%
Other
12.99%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
3747
1.12B
87.05%
-12.52M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
2023Q1
3738
1.14B
85.40%
-14.71M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
124.44M
9.71%
+807.51K
+0.65%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
68.93M
5.38%
+886.72K
+1.30%
Mar 31, 2025
State Street Global Advisors (US)
60.04M
4.69%
-392.70K
-0.65%
Mar 31, 2025
Capital Research Global Investors
41.57M
3.24%
+8.36M
+25.19%
Mar 31, 2025
JP Morgan Asset Management
27.99M
2.18%
+3.65M
+15.02%
Mar 31, 2025
Geode Capital Management, L.L.C.
27.92M
2.18%
+860.11K
+3.18%
Mar 31, 2025
MFS Investment Management
20.60M
1.61%
+1.37M
+7.14%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.57M
1.14%
-1.01M
-6.49%
Dec 31, 2024
DWS Investment GmbH
14.36M
1.12%
-297.37K
-2.03%
Mar 31, 2025
BlackRock Financial Management, Inc.
14.15M
1.1%
+923.56K
+6.99%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
Absolute Select Value ETF
5.31%
Polen Capital International Growth ETF
5.15%
Cullen Enhanced Equity Income ETF
4.57%
Madison Covered Call ETF
4.36%
iShares U.S. Medical Devices ETF
4.32%
USCF Dividend Income Fund
3.53%
First Trust Active Global Quality Income ETF
3.13%
NYLI Healthy Hearts ETF
3.07%
American Century Focused Large Cap Value ETF
3.03%
iShares Health Innovation Active ETF
2.86%
View more
Absolute Select Value ETF
Proportion5.31%
Polen Capital International Growth ETF
Proportion5.15%
Cullen Enhanced Equity Income ETF
Proportion4.57%
Madison Covered Call ETF
Proportion4.36%
iShares U.S. Medical Devices ETF
Proportion4.32%
USCF Dividend Income Fund
Proportion3.53%
First Trust Active Global Quality Income ETF
Proportion3.13%
NYLI Healthy Hearts ETF
Proportion3.07%
American Century Focused Large Cap Value ETF
Proportion3.03%
iShares Health Innovation Active ETF
Proportion2.86%
Dividend
A total of
17.37B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
